title: Cancer Risk and Behavioral Factors, Comorbidities, and Functional Status in the US Elderly Population.
abstract: About 80% of all cancers are diagnosed in the elderly and up to 75% of cancers are associated with behavioral factors. An approach to estimate the contribution of various measurable factors, including behavior/lifestyle, to cancer risk in the US elderly population is presented. The nationally representative National Long-Term Care Survey (NLTCS) data were used for measuring functional status and behavioral factors in the US elderly population (65+), and Medicare Claims files linked to each person from the NLTCS were used for estimating cancer incidence. The associations (i.e., relative risks) of selected factors with risks of breast, prostate, lung and colon cancers were evaluated and discussed. Behavioral risk factors significantly affected cancer risks in the US elderly. The most influential of potentially preventable risk factors can be detected with this approach using NLTCS-Medicare linked dataset and for further deeper analyses employing other datasets with detailed risk factors description.
authors.affiliation: Center for Population Health and Aging, Duke University, Durham, NC 27708, USA.
authors.forename: Igor
authors.initials: I
authors.lastname: Akushevich
authors.forename: Julia
authors.initials: J
authors.lastname: Kravchenko
authors.forename: Lucy
authors.initials: L
authors.lastname: Akushevich
authors.forename: Svetlana
authors.initials: S
authors.lastname: Ukraintseva
authors.forename: Konstantin
authors.initials: K
authors.lastname: Arbeev
authors.forename: Anatoliy
authors.initials: A
authors.lastname: Yashin
references.citation: JAMA. 2001 Feb 14;285(6):769-76
references.pmid: 11176915
references.citation: Cancer Causes Control. 1996 Nov;7 Suppl 1:S3-59
references.pmid: 9091058
references.citation: Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):439-46
references.pmid: 11352852
references.citation: Am J Clin Nutr. 2003 Sep;78(3 Suppl):559S-569S
references.pmid: 12936950
references.citation: Br J Cancer. 2004 Jan 26;90(2):299-303
references.pmid: 14735167
references.citation: Cancer Epidemiol Biomarkers Prev. 1994 Dec;3(8):675-82
references.pmid: 7881341
references.citation: Prostate. 2008 Jul 1;68(10):1126-32
references.pmid: 18459104
references.citation: Science. 1987 Apr 17;236(4799):271-80
references.pmid: 3563506
references.citation: N Engl J Med. 1999 Jan 21;340(3):169-76
references.pmid: 9895396
references.citation: Int J Cancer. 2009 Jan 1;124(1):245-9
references.pmid: 18814263
references.citation: J Gerontol A Biol Sci Med Sci. 1998 Jul;53(4):M251-6
references.pmid: 18314563
references.citation: J Gerontol A Biol Sci Med Sci. 2000 Jul;55(7):M418-21
references.pmid: 10898260
references.citation: J Natl Cancer Inst. 2000 Dec 6;92(23):1888-96
references.pmid: 11106680
references.citation: JAMA. 2004 Feb 4;291(5):585-90
references.pmid: 14762037
references.citation: JAMA. 2005 Jan 12;293(2):183-93
references.pmid: 15644545
references.citation: J Natl Cancer Inst. 2000 Nov 1;92(21):1740-52
references.pmid: 11058617
references.citation: Int J Cancer. 2002 Mar 10;98(2):241-56
references.pmid: 11857415
references.citation: Am J Psychiatry. 2001 Jun;158(6):848-56
references.pmid: 11384888
references.citation: Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1977-83
references.pmid: 17035408
references.citation: Cancer. 2009 Aug 15;115(16):3661-9
references.pmid: 19598210
references.citation: Am J Epidemiol. 2005 Mar 1;161(5):412-22
references.pmid: 15718477